Amgen submits U.S. application to sell cholesterol-fighting drug
August 28, 2014 at 09:45 AM EDT
Aug 28 (Reuters) - Amgen Inc said it submitted an application to the U.S. Food and Drug Administration to market its cholesterol-lowering drug, evolocumab.
